| Name | Title | Contact Details |
|---|---|---|
Devon Sharp |
Associate General Counsel | Profile |
Grant Riedesel |
Head of Legal, Corporate Development | Profile |
Tim Stow |
Global Head of Ethics and Compliance | Profile |
Sean Griffin |
Vice President of Regulatory Affairs | Profile |
Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.
QualChoice, our commitment is to your good health. Our vision is to become the health plan in this region that is most preferred by households, businesses, and the medical community.
MMS Holdings Inc is a Canton, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Amrus Enterprises is a Fords, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headquartered in Louisville, KY, Trilogy Health Services was founded in December 1997 and is dedicated to being the Best Healthcare Company in the Midwest by providing exceptional, comprehensive care to seniors in our living communities. Trilogy has over 100 locations and continues to grow across IN, OH, MI and KY. Join our growing company and experience the Trilogy Difference.